Prediction Case File
YouTubeTracking Live

NVDA's Fallen, Where do I put MY money?

5 extracted signals · 0 resolved · 5 still active

Jackson Buda profile imageJackson BudaIndependent analyst profile
Source published
22 Nov 2026, 21:30 UTC
Recorded by Tahlil Plus
22 Nov 2026, 22:40 UTC
Video preview for NVDA's Fallen, Where do I put MY money?
Source overview

AI-generated source summary

The speaker advises patience amidst market fear and volatility, using the CBOE VIX index as a key indicator for macro buy zones (monitoring levels above 30, 40, and 50). The overall strategy is to wait for broader retail capitulation and macro flush before aggressively deploying capital into high-quality compounders and market leaders across semiconductors, retail, and fintech sectors such as AMD, Amazon, Broadcom, Walmart, and SoFi.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
5
Extracted from this source
Open
5
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    5 eligible signals linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Live evaluation in progress

    5 signals remain active.

Analyst snapshot

Jackson Buda

Platform-wide history, separate from this source evaluation.

Reliability
—
Tracked signals
13
Historical success
—
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail